- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Study shows ePocrates helps reduce med errors
Study shows ePocrates helps reduce med errorsPhysicians who use the ePocrates qRx handheld clinical drug reference guide may be avoiding more than two million adverse drug events annually, according to data extrapolated from a study presented
Study shows ePocrates helps reduce med errors
Physicians who use the ePocrates qRx handheld clinical drug reference guide may be avoiding more than two million adverse drug events annually, according to data extrapolated from a study presented at the annual meeting of the American Medical Informatics Association. Investigators at Brigham and Women's Hospital in Boston conducted a seven-day online survey of ePocrates users during March. Some 870 physicians participated via e-mail; of these, 50% indicated that the qRx helped them avoid one or more adverse drug events per week. qRx was launched last November and is now used by more than 80,000 physicians, according to the company.
- Search Again
- Return To HNN Homepage
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
